Advanced Neuro- Science Allies Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
- Paid Up Capital ₹ 1.70 Cr
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.15 Cr
- Revenue Growth %
- Profit Growth 37.60%
- Ebitda -1035.00%
- Net Worth -0.07%
- Total Assets -0.32%
About Advanced Neuro- Science Allies
Advanced Neuro- Science Allies Private Limited (ANSAPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 May 2009 and has a history of 15 years and eight months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.70 Cr.
The company currently has active open charges totaling ₹3.15 Cr.
Neelam Venkataramana, Sripada Rao, and Raghavendra Murthy serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85199KA2009PTC049821
-
Company No.
049821
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 May 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Advanced Neuro- Science Allies?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Neelam Venkataramana | Director | 12-May-2009 | Current |
Sripada Rao | Director | 01-Nov-2010 | Current |
Raghavendra Murthy | Director | 01-Jul-2021 | Current |
Financial Performance of Advanced Neuro- Science Allies.
Advanced Neuro- Science Allies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 37.6% increase in profit. The company's net worth dipped by a decrease of 0.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Neuro- Science Allies?
Unlock access to Advanced Neuro- Science Allies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.15 Cr
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank : 2.65 Cr
- Department Of Biotechnology : 0.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
07 Mar 2013 | Corporation Bank | ₹4.00 M | Open |
19 Dec 2011 | Department Of Biotechnology | ₹5.00 M | Open |
12 Sep 2009 | Corporation Bank | ₹2.25 Cr | Open |
How Many Employees Work at Advanced Neuro- Science Allies?
Advanced Neuro- Science Allies has a workforce of 18 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Neuro- Science Allies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Neuro- Science Allies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.